About Innova Medical Group
Innovations for global benefit
Innova Medical Group Leverages healthcare and medical device expertise to build an end-to-end ecosystem in response to the pandemic.
Innova Medical Group, Inc. delivers better global health outcomes with its deep expertise in testing and unique offerings in diagnostic medical devices and services that help tackle some of the world’s most challenging healthcare problems. Innova specializes in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases.
In response to the global pandemic, Innova developed an end-to-end ecosystem of rapid diagnostic and screening tests, along with digital reporting and tracing applications to help organizations manage the COVID-19 crisis. In 2020, Innova delivered more than 220+ million COVID-19 test kits to over 20 countries around the globe, including the United Kingdom, Hungary, Singapore, United Arab Emirates and Myanmar.
As a leader in the research and development of in-vitro diagnostic reagents and test kits, Innova has improved lives with testing, monitoring, and implementing medical care. Innova Medical Group is a wholly owned subsidiary of Pasaca Capital, Inc. and is headquartered in Pasadena, CA.
Sean E. Rogers
Sean joined Innova Medical Group in February of 2021 from Citigroup, where he was most recently the Global Head of Technology Strategy and Solutions. In this role, Rogers created partnerships between established companies and promising startups, and shepherded many high-profile technology companies through capital formation, as well as mergers and acquisitions. As diagnostic medicine moves toward incorporating artificial intelligence and machine learning, Rogers’ experience in the field will assure that Innova continues to deliver sophisticated and equitable diagnostic tests. Prior to his career in Investment Banking, Sean was in Sports Marketing and Brand Management at a Leading Consumer Packaged Goods Company. He sits on the Board of Visitors for Vanderbilt University’s Owen Graduate School of Management.
PRESIDENT & CEO
Daniel Elliott is a recognized leader in business growth strategy across a diverse number of market sectors. Daniel has deep experience in identifying and commercializing leading edge technologies, corporate M&A transactions, capital investments, technology validation, successful strategic partnerships, operations and other key activities associated with business value growth.
Todd Malan, MD
CHIEF MEDICAL OFFICER
Dr. Malan has built a long record of scientific and medical innovation, both in his most recent role as the Senior Vice President of clinical research at Quantum Material Corporation and through his specialized research in stem cell therapy and regenerative medicine.
He previously served as Chief Medical Officer for iQuantum Labs, founded the investigational research for adipose derived cell therapies at the Center for Regenerative Cell Medicine, and served as Medical Director for adipose tissues services at Celebration Stem Cell Labs in Arizona. He holds board certifications from the American Board of Regenerative Medicine, the American Board of Obstetrics and Gynecology and the American Board of Cosmetic Surgery. He earned his medical degree from University of Arizona College of Medicine.
CHIEF LEGAL OFFICERAs a licensed attorney in California and Texas, Robert has played a critical role in private and public start-ups, as well as mergers and acquisitions for both domestic and international clients. Robert’s career includes serving as Managing Officer of a multi-national battery manufacturer as well as serving as an officer and/or director of several US-based operating companies. Robert is an experienced executive in regulatory compliance, product commercialization and quality assurance for complex and technical products globally. Robert received his bachelor’s degree in Political Science from CSUSB and attended law school at the University of La Verne, College of Law.
CHIEF OPERATING OFFICERMike brings years of experience in operating businesses as well as in leading digital and strategic transformations of both B2C and B2B companies with leadership positions in marketing, technology, product, sales, and strategy. His experience extends across multiple industries with both public and private companies, including emerging start-ups and the U.S. military where he started his career an intelligence officer serving in Germany and Bosnia. Prior to Innova, Mike served various leadership roles at Experian since 2014 and most recently as Global Managing Director of Data Quality division. Mike earned his Master’s in public administration from Princeton University and B.A. in international relations from Notre Dame University.
CHIEF INFORMATION OFFICERMarc has championed successful agile, digital and cloud transformations and has led teams that developed widely used web, iOS and Android apps as well as APIs that sit at the heart of some the largest and best-known Internet brands. Marc’s teams have been recognized with 2019 and 2020 ISO/IEC 27001 Information Security Management certifications. Marc joined Innova from Generali Global Assistance, where he served as their CIO. Before that he held various IT leadership positions in Fortune 500 and mid-market companies including the Ford Motor Company, Science Application International Corporation and Hunter Industries. Marc earned both his MBA and B.S. from Indiana University Kelly School of Business.
Robbin Xu, Ph.D.
DIRECTOR, CLINICAL PROGRAMS
Dr. Xu serves as Director of Clinical Programs and is responsible for managing clinical projects that improve global health. Dr. Xu also serves as a bioscience advisor to the Innova leadership team. Earning his Ph.D. at the University of Virginia in Charlottesville, Dr. Xu focused his research on identifying metalloprotease genes, neuralization, and Wnt signaling pathways.
The Wnt pathway offers clinical importance by studying mutations that lead to various diseases including breast, brain and prostate cancer, and Type 2 diabetes. Robbin has published many papers supporting his earlier research in Biochemistry and Cell Biology. Besides his impressive bioscience research, Dr. Xu has served as a scientific analyst, specializing in biotech investments, for American Compass, Inc. prior to joining Innova.
CHIEF COMMERCIAL OFFICER
Eric pairs innovation with decades of senior leadership experience at technology-driven firms, including Alcatel-Lucent. He served as CEO and president for Asoka USA Corporation. His key roles at Pasaca Capital and Innova Medical Group, Inc. tap into his proven success of driving growth and profitability by structuring critical partnerships and securing new business with leading global corporations.
Eric earned his Master of Philosophy and International Business and Finance from New York University’s School of Business after graduating with Honors with a Bachelor of Science, Computer and Information Sciences, from Queen’s University in Canada. Eric also served as an adjunct faculty member at NYU, teaching International Financial Management and International Trade Theory and Commercial Policy.
VICE PRESIDENT, SALES
Kyle brings over 20 years of successful commercial leadership experience in innovative and disruptive medical devices to Innova Medical Group. He serves as Vice President, Sales and is responsible for the global growth of Innova Med Group’s product portfolio.
He has extensive experience in new concept introduction, team development, reimbursement, channel development and sales strategy implementation and has served key leadership positions in several large pharmaceutical and medical devices companies including Dexcom, Inc. and Medtronic. Kyle received his Bachelor’s in Biological Sciences from the University of California, Santa Barbara as well as a Master’s in Business Administration from Arizona State University’s W.P. Carey School of Business.
VICE PRESIDENT, EMEA
Xavier leads the EMEA market for Innova Medical Group. With a chemical engineering and organic chemistry background, Xavier’s accomplishment spans an array of diversified industries including chemicals,pharmaceuticals, environment and energy for Fortune 500 companies as well as startups.
His different tenures in Europe and in the USA have defined him as a thoughtful leader with unique capabilities to manage complex projects through purposeful thinking. Xavier earned his M.S. in Industrial Engineering from Université de Technologie de Compiègne and an M.S. in Organic and Mineral Chemistry from Ecole supérieure de Chimie organique et minérale.
INNOVA MEDICAL GROUP, Inc.
INNOVA MEDICAL EUROPE LIMITED
MPS Medical, Inc.
A Wholly Owned Subsidiary of Innova Medical Group
Biological Laboratory, Inc (BIOLAB), an accredited clinical laboratory, has been servicing the healthcare community since 1998. In response to the COVID-19 pandemic, BIOLAB expanded testing throughout the United States covering the full spectrum of COVID-19 detection with services ranging from antibodies, antigen, and RT-PCR testing to keep communities safe.